GG
HELP

Gofen & Glossberg’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Gofen & Glossberg’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,053
Closed -$48K – 620
2021
Q4 		$48K Buy
1,053
+395
+60% +$25K ﹤0.01% 602
2021
Q3 		$55K Buy
+658
New +$57.6K ﹤0.01% 593

Other funds holding HELP

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PCC
Perry Creek Capital New York $218M AUM 18.4% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
T
TCWP Beachwood, Ohio $40.8M AUM 31.25% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Gofen & Glossberg's HELP Position: Q1 2022 in Review

Gofen & Glossberg sold out of Helus Pharma Inc. Common Stock (HELP) in Q1 2022, closing a stake of 1,053 shares — an estimated $48K sold.

Gofen & Glossberg first reported a position in HELP in Q3 2021 and held it in 2 quarters. The position peaked at $55K in Q3 2021. 51 funds tracked by Wall St. Rank hold HELP as of Q1 2022.

  • Gofen & Glossberg reported no remaining Helus Pharma Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Gofen & Glossberg sold 1,053 Helus Pharma Inc. Common Stock shares in Q1 2022, an estimated $48K.
  • Gofen & Glossberg first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Gofen & Glossberg's Helus Pharma Inc. Common Stock position peaked at $55K in Q3 2021.
  • 51 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q1 2022.

Based on Gofen & Glossberg's 13F filing for Q1 2022, filed 14 Apr 2022.